Sign in

CIK 0000885590

  • Large accelerated filer

Bausch Health Companies Inc.

Sign in to watch
Ticker
BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
Phone
+1 514-744-6792
Business address
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
Former names
Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
  1. 4 Grant or award Director acquired 1,750 shares (grant or award)
  2. 4 Open-market buy Director bought 948,353 shares at $19.24 ($18,246,312)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market buy Director bought 5,000,000 shares at an average $16.65 ($83,251,536)
  5. 4 Shares withheld for taxes CHAIRMAN & CEO gave up 95,489 shares (to pay taxes)
  6. 4 Shares withheld for taxes Director gave up 624 shares (to pay taxes)
  7. 4 Grant or award Director acquired 11,037 shares (grant or award)
  8. 4 Grant or award Director acquired 11,037 shares (grant or award)
  9. 4 Grant or award Director acquired 11,037 shares (grant or award)
  10. 4 Grant or award Director acquired 11,037 shares (grant or award)
  11. 4 Grant or award Director acquired 11,037 shares (grant or award)
  12. 4 Grant or award Director acquired 11,037 shares (grant or award)
  13. 4 Grant or award Director acquired 11,037 shares (grant or award)
  14. 4 Grant or award Director acquired 11,037 shares (grant or award)
  15. 4 Shares withheld for taxes Director gave up 624 shares (to pay taxes)
  16. 4 Grant or award Director acquired 443 shares (grant or award)
  17. 4 Grant or award Director acquired 2,419 shares (grant or award)
  18. 4 Grant or award Director acquired 1,774 shares (grant or award)
  19. 4 Grant or award Director acquired 2,016 shares (grant or award)
  20. 4 Open-market buy Director bought 2,500 shares at $15.54 ($38,838)

Page 18 of 61 · 1,214 filings